We provide drug safety data and literature monitoring solutions to help you maintain patient safety and compliance with less pain
Literature monitoring for pharmacovigilance can be painful. Staff are burdened with challenges such as ineffective search, manual workload, and GxP certification concerns. Companies must streamline decentralized processes and information management, access key data sources, and automate detection of safety signals.
How we help
We are a global leader in scientific data and analytics, offering comprehensive drug safety data sources and extensive experience alleviating challenges with pharmacovigilance processes. Our pharmacovigilance solutions — QUOSA PV, Embase and PharmaPendium — are used by practitioners to achieve pharmacovigilance with less pain and more efficiency.
We help our customers:
- Quickly detect adverse event information across various types of scientific literature
- Automate and centralize information monitoring and triage with detailed audit trails
- Use more effective information search strategies
Ready to take the next step?
- Generate audit-ready reports
- Track progress and manage workload of literature review staff members
- Access FDA/EMA drug approval and comparative drug safety data
Elsevier's R&D Solutions - Pharma & Life Sciences Solution Finder
Answer a few questions to see which of our pharma & life sciences solutions can help you. From drug discovery to post-market, we offer solutions that can help you drive commercial success and manage risk.
Find the right solutions for your needs
Thousands of pharmacovigilance, drug safety and information practitioners rely on our solutions.
Ensuring compliant Monitoring of Adverse Events
Compliance is critical — because missing adverse events is simply not an option. Find out how Elsevier R&D Professional Services helped one pharmaceutical company become more compliant with literature screening requirements.
Automated literature monitoring for Pharmacovigilance
Pharmacovigilance groups depend on targeted, up-to-date product information and adverse event reporting to meet regulatory requirements. Yet, many life science enterprises are compromised by multiple databases that lack integration, and feature insufficient search and alert functions.
Elsevier's R&D Solutions for Pharmacovigilance
Promote efficiency and organizational compliance by centralizing the discovery of adverse event information and automating information monitoring and triage in a scalable environment.
Learn more about QUOSA PV
Make more informed drug development decisions on safety and efficacy, risk assessments and mitigation, and study designs by providing researchers with searchable FDA/EMA drug approval documents and comparative drug safety data.
Learn more about PharmaPendium
Improve literature monitoring for adverse events with the world’s most comprehensive biomedical literature database.
Learn more about Embase
Streamline literature monitoring for adverse events by validating search strategies and implementing solutions for literature triage and review.
Learn more about Professional Services
Ideas and insights for industry professionals
Designing and Validating Effective Search Formulas for Literature Monitoring
The FDA and EMA expect 100% of adverse drug reactions to be found in the literature monitoring process, so your search formula must be designed to achieve perfect recall. At the same time, though, you want to minimize the number of irrelevant records retrieved in order to maintain efficiency.
Read the white paper
Pharmacovigilance requires the right tools
Literature monitoring can help you report adverse events fast only if your process is up-to-date. With more data today than ever before — and more adverse events reported — monitoring has become more challenging. But the right solutions can help you.